Δ10-19GeXIVA

General Information


DCTPep ID  DCTPep06229

Peptide Name   Δ10-19GeXIVA

Sequence  RSPYDRRRRY

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

ACP Cancer targeted peptides α9α10nAChR inhibitor



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  α9α10nAChR

Affinity  IC50=1110 nM (Blocking α9α10nAChR)

Mechanism  Specifically block the α9α10nAChR



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

SequenceNo structure available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C60H97N25O16

Absent amino acids  ACEFGHIKLMNQTVW

Theoretical pI  11.44

Acidic residues  1

Basic residues  5

Polar residues  3

Molecular weight (Average)  1424.59

Molecular weight (Monoisotopic)  1423.75

Common amino acids  R

Net charge  4

Instability index (II)  277.32

Aliphatic index  0.00

Grand average of hydropathicity (GRAVY)  -3.100

Half Life 
  1 hours (mammalian reticulocytes, in vitro).
  2 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 2980
  Abs 0.1% (=1 g/l) 2.092

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN112010961A

Patent Title  Novel alpha O-conotoxin peptide GeXIVA new mutant as well as pharmaceutical composition and application thereof

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.